June 2019
  • Mergers & acquisitions

Founded in 2006 and based in La Tronche (Isère), ENDOCONTROL designs, manufactures and markets robotic assisted solutions for mini-invasive surgery.

The company offers two ranges of products:

  • VIKY: ultra-compact robotic endoscopic positioner and uterus positioner via voice or foot control;
  • JAIMY: a robotic articulated surgical instrument for mini incisions (5 mm) that gives access to inaccessible intra-abdominal areas.

The Company’s technology is protected by 10 patents and various trademarks.

ENDOCONTROL serves various applications in gynecological, urological, general laparoscopic, thoracic and pediatric surgery and has sold over 200 robots in 15 countries (USA, Europe, Southeast Asia, Central America, and the Middle East).

ATOUT CAPITAL advised ENDOCONTROL’s shareholders, including SEVENTURE, ACG Management and the co-founder, Clément Vidal, for ENDOCONTROL’s sale to CANADY LIFE SCIENCES, a company part of the American Group US MEDICAL INNOVATION (USMI). USMI is a privately-held FDA registered life science, biomedical and robotic device company, run by its founder, Dr. Jerome Canady.

The ENDOCONTROL acquisition will accelerate USMI’s group entrance into the Robotic Surgical market. The ENDOCONTROL products will be sold with the Canady SR RoboticTM System for free-standing and hospital based ambulatory surgical centers and hospitals. With the help of ENDOCONTROL’s technology, USMI group aims at producing a robotic system that will cost 75% less than the current robotic systems sold today for laparoscopic and mini-invasive surgery.  

Can we help you?
In both public and private companies, Atout Capital is able
to provide a unique transversal expertise with a 360 degree approach.